Claire H Mitchell Selected Research

Claire H Mitchell Research Topics

Disease

9	Ganglion Cysts (Ganglion) 01/2016 - 06/2005
8	Glaucoma 05/2015 - 12/2008
5	Retinal Degeneration 11/2020 - 08/2012
4	Inflammation (Inflammations) 01/2021 - 05/2015
3	Pain (Aches) 01/2020 - 11/2007
3	Wounds and Injuries (Trauma) 01/2019 - 10/2014
2	Rupture 10/2018 - 01/2018
2	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 09/2014
2	Alzheimer Disease (Alzheimer's Disease) 09/2015 - 09/2014
2	Ischemia 02/2014 - 06/2008
2	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 10/2011 - 11/2007
1	Bites and Stings (Sting) 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Herpes Simplex 01/2021
1	Infections 01/2021
1	Keratitis 01/2021
1	Hemorrhage 01/2019
1	Starvation 10/2018
1	Paresthesia (Dysesthesia) 01/2018
1	Retinal Dystrophies 01/2018
1	Smith-Lemli-Opitz Syndrome 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Nervous System Diseases (Neurological Disorders) 08/2015
1	Overactive Urinary Bladder (Overactive Bladder) 04/2015
1	Abnormal Reflex (Hyperreflexia) 04/2015
1	Optic Neuritis (Retrobulbar Neuritis) 02/2014
1	Cataract (Cataracts) 10/2011
1	Muscular Dystrophies (Muscular Dystrophy) 11/2010

Drug/Important Bio-Agent (IBA)

16	Adenosine Triphosphate (ATP)IBA 01/2021 - 11/2007
5	Retinaldehyde (Retinal)IBA 01/2019 - 08/2012
4	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 09/2010 - 06/2005
3	Purinergic P2X7 ReceptorsIBA 01/2021 - 02/2014
3	Adenosine (Adenocard)FDA LinkGeneric 09/2010 - 07/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2006
2	TicagrelorIBA 01/2019 - 01/2018
2	LipofuscinIBA 01/2019 - 01/2018
2	Purinergic P2Y Receptor AntagonistsIBA 01/2019 - 01/2018
2	CalciumIBA 01/2018 - 11/2010
2	Presenilin-1IBA 09/2015 - 09/2014
2	Glutamic Acid (Glutamate)FDA Link 08/2015 - 06/2008
2	CD39 antigenIBA 05/2015 - 11/2013
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 09/2014
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2010 - 08/2006
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	HydrocarbonsIBA 01/2021
1	InterferonsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Valine (L-Valine)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Retinal Pigments (Pigments, Visual)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 10/2018
1	Acid PhosphataseIBA 10/2018
1	CholesterolIBA 01/2018
1	EnzymesIBA 01/2018
1	Carticaine (Articaine)IBA 01/2018
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018
1	trans- 1,4- Bis(2- chlorobenzaminomethyl)cyclohexane DihydrochlorideIBA 01/2018
1	glycylphenylalanineIBA 01/2018
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2018
1	ThapsigarginIBA 01/2018
1	Local AnestheticsIBA 01/2018
1	InflammasomesIBA 01/2017
1	Interleukin-3 (Interleukin 3)IBA 01/2016
1	gamma-Aminobutyric Acid (GABA)IBA 08/2015
1	Apyrase (ATP Diphosphatase)IBA 04/2015
1	6- N,N- diethyl- beta,gamma- dibromomethylene- D- ATPIBA 04/2015
1	Phenobarbital (Luminal)FDA Link 04/2015
1	Adenosine Triphosphatases (ATPase)IBA 04/2015
1	PurinesIBA 10/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2014
1	Protein Isoforms (Isoforms)IBA 02/2014
1	CytokinesIBA 02/2014
1	Ion Channels (Ion Channel)IBA 02/2014
1	Complement System Proteins (Complement)IBA 02/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2014
1	Messenger RNA (mRNA)IBA 11/2013
1	Neuroprotective AgentsIBA 09/2010
1	4- (2- chloro- 6- (3- chlorobenzylamino)- 9H- purin- 9- yl)- 2,3- dihydroxy- N- methylbicyclo(3.1.0)hexane- 1- carboxamideIBA 09/2010
1	coomassie Brilliant BlueIBA 09/2010
1	4- (3- (4- benzoylpiperazin- 1- yl)- 2- (benzyloxycarbonylamino)- 3- oxopropyl)- 3,5- dimethylphenyl 4-methylbenzenesulfonateIBA 09/2010
1	Saline SolutionIBA 09/2010
1	Coloring Agents (Dyes)IBA 08/2006
1	Complementary DNA (cDNA)IBA 08/2006
1	Fura-2 (Fura 2)IBA 08/2006
1	RNA (Ribonucleic Acid)IBA 08/2006
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 08/2006
1	CaspasesIBA 06/2005
1	YO-PRO 1IBA 06/2005

Therapy/Procedure

1	Microspheres (Microsphere) 01/2021
1	Therapeutics 01/2021
1	Cataract Extraction 11/2007